| For: | Borakati A, Froghi F, Bhogal RH, Mavroeidis VK. Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances. World J Gastroenterol 2023; 29(13): 1969-1981 [PMID: 37155529 DOI: 10.3748/wjg.v29.i13.1969] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v29/i13/1969.htm |
| Number | Citing Articles |
| 1 |
Zhiwei Zheng, Ling Fang, Hongfu Cai. Cost-effectiveness analysis of pembrolizumab in combination with chemotherapy compared with chemotherapy alone as first-line treatment for patients with advanced biliary tract cancer in China. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11255-w
|
| 2 |
Kaitlin Pardue, Molly Timmerman, Shaima Elgenaid, Lewis Hassell, Narendra R. Battula, Maheswaran Pitchaimuthu. Successful Liver Transplant From a Donor With Sickle Cell Disease. The American Surgeon™ 2024; 90(12) doi: 10.1177/00031348241268273
|
| 3 |
ARMAND N. YAZDANI, MICHAELA PLETSCH, ABRAHAM CHORBAJIAN, DAVID ZITSER, VIKRANT RAI. Emerging pharmaceutical therapies for targeting cholangiocarcinoma microenvironment and chemokine pathways. BIOCELL 2024; 48(12) doi: 10.32604/biocell.2024.056252
|
| 4 |
Abigail Miller, Kristin Hsu, Niall C. Tebbutt, Christos Karapetis, Timothy Price, Amitesh Roy. From chemotherapy to molecular targeted therapy in advanced biliary tract cancer. Academia Oncology 2026; 3(1) doi: 10.20935/AcadOnco8171
|
| 5 |
Giampaolo Perri, Jennie Engstrand, Robin D Wright, Sebastiaan F C Bronzwaer, Tiuri E Kroese, Biying Huang, Belkacem Acidi, Alessandro Vitale, Hop S Tran Cao, Richard van Hillegersberg, Magnus Nilsson, Ernesto Sparrelid, Matthew H G Katz, Giovanni Marchegiani, Umberto Cillo. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review. BJS Open 2025; 9(4) doi: 10.1093/bjsopen/zraf070
|
| 6 |
Nadine Soliman, Ashton A. Connor, Sudha Kodali, Rafik Mark Ghobrial. Liver Transplantation for Cholangiocarcinoma. Digestive Disease Interventions 2024; 8(04) doi: 10.1055/s-0044-1787171
|
| 7 |
Fei Song, Dan Xu, Jiayin Che, Ming Huang, Hongyang Li. Chitosan hydrogel incorporated with bone marrow mesenchymal stem cell-derived exosomal TIMP2 to inhibit angiogenesis in cholangiocarcinoma. Tissue and Cell 2025; 93 doi: 10.1016/j.tice.2024.102694
|
| 8 |
Fabio Melandro, Chiara Matrascia, Simona Parisse, Flaminia Ferri, Pierleone Lucatelli, Gianluca Mennini, Massimo Rossi, Quirino Lai. LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA. European Journal of Transplantation 2026; doi: 10.57603/EJT-1961
|
| 9 |
Maen Abdelrahim, Abdullah Esmail, Aiwu Ruth He, Moh’d Khushman, Yaser Rayyan. Advances in Immunotherapy for Transplant Oncology. Cancers 2024; 16(13) doi: 10.3390/cancers16132369
|
| 10 |
Ahmed A. Abdelhakeem, Conor D. O’donnell, Dina Elantably, Oluwatayo Adeoye, Hani M. Babiker, Jason Starr, Liu Yang, Jordan D. Legout, Beau Toskich, Denise M. Harnois, Jeremy C. Jones, Kristopher P. Croome, Umair Majeed. Transplant Oncology in Evolution: Emerging Roles for Liver Transplant Beyond Hepatocellular Carcinoma. Cancers 2026; 18(6) doi: 10.3390/cancers18060887
|
| 11 |
Vasileios K Mavroeidis, Francesca Saffioti, Evgenia Kotsifa. Cholangiocarcinoma: The era of liquid biopsy. World Journal of Gastroenterology 2025; 31(11): 104170 doi: 10.3748/wjg.v31.i11.104170
|
| 12 |
Jiro Kimura, Ayham Asassfeh, Matthew Cooper, Kondragunta Rajendra Prasad. Long-term outcomes of liver transplantation versus liver resection for combined hepatocellular–cholangiocarcinoma: An updated systematic review and meta-analysis. European Journal of Surgical Oncology 2026; 52(6) doi: 10.1016/j.ejso.2026.111846
|
| 13 |
Hossein Taghizadeh, Yawen Dong, Thomas Gruenberger, Gerald W. Prager. Perioperative and palliative systemic treatments for biliary tract cancer. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241230756
|
| 14 |
Christoph Schramm, Ayaz Sapuk, Dieter Hoyer, Sonia Radünz, Hartmut Schmidt. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. TumorDiagnostik & Therapie 2024; 45(04) doi: 10.1055/a-2287-1003
|
| 15 |
Mo Atif, Aditya Borakati, Vasileios K Mavroeidis. Role of routine lymph node dissection alongside resection of intrahepatic cholangiocarcinoma: Systematic review and meta-analysis. World Journal of Gastrointestinal Oncology 2023; 15(11): 2017-2032 doi: 10.4251/wjgo.v15.i11.2017
Abstract(889) |
Core Tip(902) |
Full Article(HTML)(2890)
|
Full Article (PDF)-4671K(214)
|
Full Article with Cover (PDF)-4962K(215)
|
Full Article (Word)-2361K(46)
|
Full Article (XML)-167K(148)
|
Audio-1368K(6)
|
Peer-Review Report-228K(146)
|
Answering Reviewers-79K(157)
|
Supplementary Material-105K(159)
|
Times Cited (13)
|
Total Visits (4582)
|
Open
|
| 16 |
Erlind Allkushi, Chase J. Wehrle, JaeKeun Kim, Mazhar Khalil, David C. H. Kwon, Masato Fujiki, Antonio D. Pinna, Charles Miller, Andrea Schlegel, Federico Aucejo, Koji Hashimoto, Alejandro Pita. Expanding Indications in Transplant Oncology. Cancers 2025; 17(5) doi: 10.3390/cancers17050773
|
| 17 |
Christoph Schramm, Ayaz Sapuk, Dieter Hoyer, Sonia Radünz, Hartmut Schmidt. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis – a retrospective cohort study. Zeitschrift für Gastroenterologie 2024; 62(01) doi: 10.1055/a-2207-5519
|
| 18 |
Victoria Ramdour, Thomas Lévi-Strauss, Patrick Chevallier, Delphine Ouvrier, Antonio Iannelli, Albert Tran, Rodolphe Anty. From severe acute cholangitis to aggressive intrahepatic cholangiocarcinoma: Causal or coincidental association?. Journal of Liver Transplantation 2025; 17 doi: 10.1016/j.liver.2024.100250
|
| 19 |
Rodrigo V. Motta, Francesca Saffioti, Vasileios K Mavroeidis. Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease. World Journal of Gastroenterology 2024; 30(13): 1836-1850 doi: 10.3748/wjg.v30.i13.1836
|
| 20 |
Roi Anteby, Benjamin M. Vierra, Shimul A. Shah. Liver transplant for intrahepatic cholangiocarcinoma: current evidence and clinical practice recommendations. Journal of Gastrointestinal Surgery 2025; 29(12) doi: 10.1016/j.gassur.2025.102211
|
| 21 |
Abdullah Esmail, Mohamed Badheeb, Batool Alnahar, Bushray Almiqlash, Yara Sakr, Bayan Khasawneh, Ebtesam Al-Najjar, Hadeel Al-Rawi, Ala Abudayyeh, Yaser Rayyan, Maen Abdelrahim. Cholangiocarcinoma: The Current Status of Surgical Options including Liver Transplantation. Cancers 2024; 16(11) doi: 10.3390/cancers16111946
|
| 22 |
Sofia Lopiano, James V. Guarrera, Keri E. Lunsford. Therapeutic Advances in Initially Unresectable Locally Advanced Intrahepatic Cholangiocarcinoma: Emerging Treatments and the Role of Liver Transplantation. Current Oncology 2025; 32(6) doi: 10.3390/curroncol32060293
|
| 23 |
Sibi Krishna Thiyagarajan, Arielle Jacover, Alfredo Verastegui, Katherine Poruk, John A. Stauffer. Transplant vs. Resection for Non-HCC Malignancies of the Liver. Livers 2025; 5(4) doi: 10.3390/livers5040064
|
| 24 |
Jennifer Cillis, Courtney Chen, Supriya Deshpande, Yuman Fong, Shyambabu Chaurasiya. Current Status of Drug Treatment of Cholangiocarcinoma—Updated Progress and Critical Limitations. Pharmaceuticals 2026; 19(4) doi: 10.3390/ph19040554
|